Impact on Quality of Life, Fatigue and Cognitive Function in Anti-angiogenesis in Patients With Metastatic Kidney Cancer

Predictive Value of FDG-TEP During Radiotherapy or Chemo-radiotherapy in Patients With NCSC on the One-year Survival

NCT01261598 ·Status: COMPLETED ·Phase: NA

PET-CT Based Radiotherapy in Esophageal Cancer Patients

NCT01156831 ·Status: COMPLETED

Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients

NCT06956144 ·Status: RECRUITING

Imaging Correlates of Renal Cell Carcinoma Biological Features

NCT01665703 ·Status: COMPLETED ·Phase: NA

CD70-targeted immunoPET Imaging of Kidney Cancer

NCT06680089 ·Status: RECRUITING ·Phase: PHASE2

Vascular Endothelial Growth Factor (VEGF) Imaging Before and During Everolimus Treatment for Renal Cell Carcinoma

NCT01028638 ·Status: COMPLETED

Measuring Treatment Response in Metastatic Renal Cell Cancer Using FPIA PET/CT

NCT04802824 ·Status: COMPLETED

The Predictive Value of CT-PET in Esophageal Cancer

NCT02385604 ·Status: COMPLETED

Perfusion CT as a Predictor for Response to Antiangiogenic Therapy in Patients With Metastasized Renal Cell Carcinoma

NCT02086734 ·Status: COMPLETED

Assessment of Regional Response With PET-FDG in Advanced Head and Neck Squamous Cell Carcinoma

NCT00634777 ·Status: UNKNOWN ·Phase: NA

Role of PET Scan in the Evaluation of Early Response to Maintenance Treatment in Advanced Non-small-cell Lung Cancer

NCT02507518 ·Status: UNKNOWN ·Phase: PHASE2

A Proof-of-concept Study to Assess the Ability of [18F]AH-111585 PET Imaging to Detect Tumours and Angiogenesis

NCT00565721 ·Status: COMPLETED ·Phase: PHASE2

The Role of the Imaging FAPI PET/CT in Exploring the Microenvironment of Colorectal Cancer Liver Metastases

NCT07109440 ·Status: RECRUITING ·Phase: NA

Assessment of Bone Biomarkers for TKI Response in RCC With Bone Metastases, HRQoL and Comparison of Imaging Techniques

NCT02747173 ·Status: TERMINATED

RGD-PET-CT in Cancer Angiogenesis

NCT01492192 ·Status: TERMINATED ·Phase: PHASE2

A Small-molecule Carbonic Anhydrase IX Targeting PET Tracer in Clear Cell Renal Cell Carcinoma

NCT05728515 ·Status: COMPLETED ·Phase: EARLY_PHASE1

Pre-surgical Detection of Clear Cell Renal Cell Carcinoma (ccRCC) Using Radiolabeled G250-Antibody

NCT00606632 ·Status: COMPLETED ·Phase: PHASE3

Dual-energy SPEctral CT to Evaluate Response to First-line Therapies in Patients With Metastatic Clear Cell REnal Cancer

NCT06863857 ·Status: RECRUITING

[18F] PSMA-1007 PET/CT in Metastatic Clear Cell Renal Cell Carcinoma

NCT06428708 ·Status: RECRUITING ·Phase: EARLY_PHASE1

Early Versus Late FDG-PET/CT in Bladder Cancer

NCT03065725 ·Status: COMPLETED

PET Evaluation of Response After 1 Course of Chemotherapy as Predictor of Treatment Outcome.

NCT00741481 ·Status: COMPLETED

Local Recurrence Prediction of by Texture Analysis Derived From Positron Emission Tomography (PET / CT) Imaging of Non-small Cell Lung Cancer (NSCLC) Treated With Stereotactic Radiotherapy (SBRT) (Retros MUMOFRAT)

NCT06555861 ·Status: COMPLETED

Evaluating the roLe of Multiplexed PET Imaging in the Detection and Staging of hepatocellulaR Carcinoma and gAstro-entero-pancreatic Tumors

NCT07178587 ·Status: RECRUITING ·Phase: NA

Evaluation of Fapi-pet in Prostate Cancer.

NCT05192694 ·Status: UNKNOWN ·Phase: NA

68Ga-PSMA PET in the Renal Cell Carcinoma

NCT04987086 ·Status: RECRUITING ·Phase: NA